Vanderbilt Brain Institute

The Vanderbilt Brain Institute will present “Rethinking General Anesthesia” on Wednesday, Jan. 12, beginning at 4 p.m. CT. Read More

Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read More

Vanderbilt researchers push research on ketamine’s role as a rapid antidepressant another step forward. This work opens avenues for new therapeutics for half of people for whom today’s antidepressants don’t work. Read More

Lisa Monteggia and her lab have identified how specific neurons in the hippocampus work to produce ketamine’s antidepressant action. Est. reading time: 2 mins. Read More

Eight-week mindfulness programs improve brain health in people over 60. Read More

Discovery shows that dopamine is not a reward molecule at all, calling for revision of textbook facts regarding the hormone’s role in the brain. Est. reading time: 3.5 mins. Read More

Even in the absence of brain activity, nerve cells can turn on gene expression that is important for antidepressant effects. This novel finding from Lisa Monteggia gives researchers a more fundamental understanding of the brain’s mechanistic function for better therapeutics. Est. reading time: 2.5 mins. Read More

Calling all lifelong learners 50 and older to the Osher Lifelong Learning Institute at Vanderbilt, which has announced its fall term of courses. They include: ’60s music, the U.S. women’s movement, Latin American-U.S. relations, elements of film and more. Read More

Lisa Monteggia leads discovery of the gene responsible for ketamine’s long-term effects with implications for antidepressant therapeutics. Est. reading time: 2.5 mins. Read More

Vanderbilt’s Data Science Institute has kicked off the third year of its undergraduate summer research program. The program engages students who are interested in carrying out data science-related research with a Vanderbilt faculty member and integrates them into the institute’s community of data science scholars. Read More

Research led by Lisa Monteggia reveals that ketamine provides antidepressant effects by blocking key neural pathway. Est. reading time: 3 mins. Read More

By studying extracellular vesicles from the brain, researchers at Vanderbilt and Argentina’s Universidad Nacional de Córdoba are the first to show how the incorporation of extracellular proteins into a neuron can modify neurotransmission Read More

Celebrated neuroscientist and author of Still Alice to join Vanderbilt Brain Institute for discussion on How the Brain Remembers. Read More

A transdisciplinary team from Vanderbilt, Soterix Medical and the U.S. Army has advanced to the finals of the U.S. Army Medical Research and Development Command’s xTechBOLT competition, where they will compete in November with four other teams for the $500,000 first-place prize. Read More

Join the School of Medicine Basic Sciences for a virtual conversation with "New York Times" bestselling author and neuroscientist Lisa Genova and Vanderbilt Brain Institute Barlow Family Director Lisa Monteggia. They will be discussing Genova's new book, "Remember: The Science of Memory and the Art of Forgetting," on Wednesday, May 26, from 11 a.m. to noon CT. Read More

Richard Tsien, PhD, director of the Neuroscience Institute at NYU Langone Medical Center, will deliver the next web-based Discovery Lecture. Read More

Brain Awareness Week is March 15–21, and the Vanderbilt Brain Institute will host Brain Blast, its annual outreach event. This year’s event will be entirely virtual, so participants can explore Brain Blast activities and videos from any location. Read More

Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease. Read More

Brain inflammation links genetic and acquired epilepsy — providing new clues about epilepsy development and pointing to potential treatments. Read More

Further research by biochemistry professors Charles Sanders and  Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read More